v3.26.1
Fair Value Measurements (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Oct. 31, 2025
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Carrying value of investment   $ 24,855,000     $ 24,855,000   $ 0
Fair value liability transfers into level 3   0          
Fair value liability transfers out of level 3   0          
Fair value liability level 1 to level 2 transfers amount   0          
Fair value liability level 2 to level 1 transfers amount   0          
IsoBio Inc [Member]              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Carrying value of investment   5,600,000     5,600,000   5,600,000
Unrealized gain $ 600,000            
Opeongo [Member]              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Carrying value of investment   10,000,000     10,000,000    
ENDRA Life Sciences, Inc [Member]              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Carrying value of investment   3,800,000     3,800,000    
Skyline [Member]              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Carrying value of investment   24,900,000     24,900,000    
Initially recorded investment under equity method         23,800,000    
Adjusted carrying amount of investment under equity method     $ 1,100,000        
Change in fair value of investment   0   $ 0 1,100,000 $ 1,100,000  
Convertible Notes Payable [Member]              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Fair value on a recurring basis   $ 203,400,000     $ 203,400,000   $ 199,300,000